{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T12:37:17Z","timestamp":1763728637939,"version":"3.41.2"},"reference-count":31,"publisher":"FapUNIFESP (SciELO)","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Inst. Med. trop. S. Paulo"],"DOI":"10.1590\/s1678-9946202365059","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T14:46:33Z","timestamp":1701441993000},"source":"Crossref","is-referenced-by-count":3,"title":["Real-world effectiveness and safety of direct-acting antivirals for the treatment of hepatitis C virus in kidney and liver transplant recipients: experience of a large transplant center in Brazil"],"prefix":"10.1590","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0540-2696","authenticated-orcid":false,"given":"Larissa Sgaria","family":"Pacheco","sequence":"first","affiliation":[{"name":"Universidade Federal de Ci\u00eancias da Sa\u00fade de Porto Alegre,  Brazil; Irmandade da Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5235-2804","authenticated-orcid":false,"given":"Pedro Enrico","family":"Ventura","sequence":"additional","affiliation":[{"name":"Irmandade da Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7338-2431","authenticated-orcid":false,"given":"Roger","family":"Kist","sequence":"additional","affiliation":[{"name":"Irmandade da Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7394-1501","authenticated-orcid":false,"given":"Valter Duro","family":"Garcia","sequence":"additional","affiliation":[{"name":"Irmandade da Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6784-0894","authenticated-orcid":false,"given":"Gisele","family":"Meinerz","sequence":"additional","affiliation":[{"name":"Irmandade da Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7932-5937","authenticated-orcid":false,"given":"Cristiane Valle","family":"Tovo","sequence":"additional","affiliation":[{"name":"Universidade Federal de Ci\u00eancias da Sa\u00fade de Porto Alegre,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8808-4119","authenticated-orcid":false,"given":"Guido Pio Cracco","family":"Cantisani","sequence":"additional","affiliation":[{"name":"Irmandade da Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9167-1202","authenticated-orcid":false,"given":"Maria Lucia","family":"Zanotelli","sequence":"additional","affiliation":[{"name":"Irmandade da Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9389-2236","authenticated-orcid":false,"given":"Marcos","family":"Mucenic","sequence":"additional","affiliation":[{"name":"Universidade Federal de Ci\u00eancias da Sa\u00fade de Porto Alegre,  Brazil; Irmandade da Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5519-8224","authenticated-orcid":false,"given":"Elizete","family":"Keitel","sequence":"additional","affiliation":[{"name":"Universidade Federal de Ci\u00eancias da Sa\u00fade de Porto Alegre,  Brazil; Irmandade da Santa Casa de Miseric\u00f3rdia de Porto Alegre,  Brazil"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"530","published-online":{"date-parts":[[2023]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/S2468-1253(16)30181-9","article-title":"Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study","volume":"2","year":"2017","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/j.jhep.2018.05.011","article-title":"Burden of liver disease in Europe: epidemiology and analysis of risk factors to identify prevention policies","volume":"69","author":"Pimpin L","year":"2018","journal-title":"J Hepatol"},{"series-title":"Global progress report on HIV, viral hepatitis and sexually transmitted infections, 2021: accountability for the global health sector strategies 2016\u20132021: actions for impact","key":"ref3"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/jvh.12148","article-title":"Meta-analysis of observational studies: hepatitis C and survival after renal transplant","volume":"21","author":"Fabrizi F","year":"2014","journal-title":"J Viral Hepat"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1097\/01.TP.0000131948.29742.24","article-title":"Hepatitis C infection, time in renal-replacement therapy, and outcome after kidney transplantation","volume":"78","author":"Bruchfeld A","year":"2004","journal-title":"Transplantation"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000332389","article-title":"Impact of extrahepatic complications (diabetes and glomerulonephritis) associated with hepatitis C virus infection after renal transplantation","volume":"176","author":"Cruzado JM","year":"2012","journal-title":"Contrib Nephrol"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1097\/TP.0b013e3181f92548","article-title":"Adverse impact of hepatitis C virus infection on renal replacement therapy and renal transplant patients in Australia and New Zealand","volume":"90","author":"Scott DR","year":"2010","journal-title":"Transplantation"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0016-5085(92)91129-R","article-title":"Recurrent and acquired hepatitis C viral infection in liver transplant recipients","volume":"103","author":"Wright TL","year":"1992","journal-title":"Gastroenterology"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"S36","DOI":"10.1002\/lt.21646","article-title":"The natural history of recurrent hepatitis C and what influences this","volume":"14","author":"Gane EJ","year":"2008","journal-title":"Liver Transpl"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1053\/gast.2002.32418","article-title":"The association between hepatitis C infection and survival after orthotopic liver transplantation","volume":"122","author":"Forman LM","year":"2002","journal-title":"Gastroenterology"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"S-1001","DOI":"10.1016\/S0016-5085(15)33417-X","article-title":"Final evaluation of 955 HCV patients treated with 12 week regimens containing sofosbuvir+\/-simeprevir in the trio network: academic and community treatment of a real-world, heterogeneous population","volume":"148","author":"Dieterich D","year":"2015","journal-title":"Gastroenterology"},{"key":"ref12","doi-asserted-by":"crossref","DOI":"10.1590\/s1678-9946202163006","article-title":"A real-life study on the impact of direct-acting antivirals in the treatment of chronic hepatitis C in liver transplant recipients at two university centers in Northeastern Brazil","volume":"63","author":"Silva IP","year":"2021","journal-title":"Rev Inst Med Trop S\u00e3o Paulo"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1111\/ajt.13620","article-title":"Successful treatment of hepatitis C in renal transplant recipients with direct-acting antiviral agents","volume":"16","author":"Sawinski D","year":"2016","journal-title":"Am J Transplant"},{"volume-title":"Secretaria de Vigil\u00e2ncia em Sa\u00fade, Departamento de Vigil\u00e2ncia, Preven\u00e7\u00e3o e Controle das Infec\u00e7\u00f5es Sexualmente Transmiss\u00edveis, do HIV\/Aids e das Hepatites Virais","year":"2011","series-title":"Protocolo cl\u00ednico e diretrizes terap\u00eauticas para hepatite C e coinfec\u00e7\u00f5es","key":"ref14"},{"volume-title":"Secretaria de Vigil\u00e2ncia em Sa\u00fade, Departamento de Vigil\u00e2ncia, Preven\u00e7\u00e3o e Controle das Infec\u00e7\u00f5es Sexualmente Transmiss\u00edveis, do HIV\/Aids e das Hepatites Virais","year":"2017","series-title":"Protocolo cl\u00ednico e diretrizes terap\u00eauticas para hepatite C e coinfec\u00e7\u00f5es","key":"ref15"},{"volume-title":"Secretaria de Vigil\u00e2ncia em Sa\u00fade, Departamento de Vigil\u00e2ncia, Preven\u00e7\u00e3o e Controle das Infec\u00e7\u00f5es Sexualmente Transmiss\u00edveis, do HIV\/Aids e das Hepatites Virais","year":"2019","series-title":"Protocolo cl\u00ednico e diretrizes terap\u00eauticas para hepatite C e coinfec\u00e7\u00f5es","key":"ref16"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1002\/hep.21178","article-title":"Development of a simple noninvasive index to predict significant fibrosis in patients with HIV\/HCV coinfection","volume":"43","author":"Sterling RK","year":"2006","journal-title":"Hepatology"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1053\/jhep.2003.50346","article-title":"A simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis C","volume":"38","author":"Wai CT","year":"2003","journal-title":"Hepatology"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep.20506","article-title":"Noninvasive assessment of liver fibrosis by measurement of stiffness in patients with chronic hepatitis C","volume":"41","author":"Ziol M","year":"2005","journal-title":"Hepatology"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.transproceed.2020.01.021","article-title":"Eliminating hepatitis C virus from a prevalent kidney transplant recipient population: a single-center study in Belgium in the direct-acting antivirals era","volume":"52","author":"Devresse A","year":"2020","journal-title":"Transplant Proc"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"100337","DOI":"10.1016\/j.aohep.2021.100337","article-title":"\u2018Real-life\u2019 experience with direct-acting antiviral agents for HCV after kidney transplant","volume":"25","author":"Fabrizi F","year":"2021","journal-title":"Ann Hepatol"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S1473-3099(15)70099-X","article-title":"Ledipasvir and sofosbuvir fixed-dose combination with and without ribavirin for 12 weeks in treatment-naive and previously treated Japanese patients with genotype 1 hepatitis C: an open-label, randomised, phase 3 trial","volume":"15","author":"Mizokami M","year":"2015","journal-title":"Lancet Infect Dis"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1002\/hep.27890","article-title":"Safety and tolerability of ledipasvir\/sofosbuvir with and without ribavirin in patients with chronic hepatitis C virus genotype 1 infection: analysis of phase III ION trials","volume":"62","author":"Alqahtani SA","year":"2015","journal-title":"Hepatology"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"P199","DOI":"10.1016\/j.jhep.2015.03.025","article-title":"EASL recommendations on treatment of hepatitis C 2015","volume":"63","year":"2015","journal-title":"J Hepatol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.transproceed.2018.02.001","article-title":"Daclatasvir and sofosbuvir with or without ribavirin in liver transplant recipients: a single-center real-world study","volume":"50","author":"Mucenic M","year":"2018","journal-title":"Transplant Proc"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.bjid.2019.10.011","article-title":"Treatment of chronic hepatitis C in patients with chronic kidney disease with Sofosbuvir-basead regimes","volume":"24","author":"Rossato G","year":"2020","journal-title":"Braz J Infect Dis"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1177\/1060028015576180","article-title":"Drug interactions with direct-acting antivirals for hepatitis C: implications for HIV and transplant patients","volume":"49","author":"Burgess S","year":"2015","journal-title":"Ann Pharmacother"},{"key":"ref28","doi-asserted-by":"crossref","DOI":"10.1111\/tid.13078","article-title":"Impact of direct\u2010acting antivirals for hepatitis C virus therapy on tacrolimus dosing in liver transplant recipients","volume":"21","author":"Bixby AL","year":"2019","journal-title":"Transpl Infect Dis"},{"key":"ref29","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1111\/ajt.15053","article-title":"Immune-mediated graft dysfunction in liver transplant recipients with hepatitis C virus treated with direct-acting antiviral therapy","volume":"18","author":"Chan C","year":"2018","journal-title":"Am J Transplant"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"180","DOI":"10.4254\/wjh.v9.i4.180","article-title":"Interferon-free regimens in patients with hepatitis C infection and renal dysfunction or kidney transplantation","volume":"9","author":"Cholongitas E","year":"2017","journal-title":"World J Hepatol"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12876-019-0973-5","article-title":"Rapid decline of noninvasive fibrosis index values in patients with hepatitis C receiving treatment with direct-acting antiviral agents","volume":"19","author":"Hsu WF","year":"2019","journal-title":"BMC Gastroenterol"}],"container-title":["Revista do Instituto de Medicina Tropical de S\u00e3o Paulo"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0036-46652023000100225&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T14:46:43Z","timestamp":1701442003000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0036-46652023000100225&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"references-count":31,"alternative-id":["S0036-46652023000100225"],"URL":"https:\/\/doi.org\/10.1590\/s1678-9946202365059","relation":{},"ISSN":["1678-9946"],"issn-type":[{"type":"electronic","value":"1678-9946"}],"subject":[],"published":{"date-parts":[[2023]]},"article-number":"e59"}}